Assessment of Compliance With Antihypertensive Telmisartan Therapy

• Status: Completed
• Trial end date: 2010-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bayer
• Collaborator: Bang & Olufsen Medicom
• Treatments: Antihypertensive Agents; Telmisartan

Criteria

Inclusion Criteria:

• Age over 18

• Untreated or ineffectively treated arterial hypertension

Exclusion Criteria:

• Cholestatic disorders and severe hepatic failure

• Allergy to Telmisartan

• Pregnancy and lactation period

• Unwillingness to participate in the study

• Inability to use the drug reminder device

• Unwillingness to use the drug reminder device